206 related articles for article (PubMed ID: 36556123)
1. Cuproptosis-Related Genes Are Associated with Cell Cycle and Serve as the Prognostic Signature for Clear Cell Renal Cell Carcinoma.
Guo T; Zhang J; Yuan Z; Tang H; Wang T; Wang X; Chen S
J Clin Med; 2022 Dec; 11(24):. PubMed ID: 36556123
[TBL] [Abstract][Full Text] [Related]
2. Identification and Validation of Cuproptosis-Related Prognostic Signature and Associated Regulatory Axis in Uterine Corpus Endometrial Carcinoma.
Chen Y
Front Genet; 2022; 13():912037. PubMed ID: 35937995
[No Abstract] [Full Text] [Related]
3. Cuproptosis-Related Genes MTF1 and LIPT1 as Novel Prognostic Biomarker in Acute Myeloid Leukemia.
Li Y; Kan X
Biochem Genet; 2024 Apr; 62(2):1136-1159. PubMed ID: 37561332
[TBL] [Abstract][Full Text] [Related]
4. Database Mining Detected a Cuproptosis-Related Prognostic Signature and a Related Regulatory Axis in Breast Cancer.
Jiang B; Zhu H; Feng W; Wan Z; Qi X; He R; Xie L; Li Y
Dis Markers; 2022; 2022():9004830. PubMed ID: 36312586
[TBL] [Abstract][Full Text] [Related]
5. A novel cuproptosis-related prognostic gene signature in adrenocortical carcinoma.
Gao W; He X; Huangfu Q; Xie Y; Chen K; Sun C; Wei J; Wang B
J Clin Lab Anal; 2023 Nov; 37(21-22):e24981. PubMed ID: 37997497
[TBL] [Abstract][Full Text] [Related]
6. A novel prognostic signature of cuproptosis-related genes and the prognostic value of FDX1 in gliomas.
Zhu H; Wan Q; Tan J; Ouyang H; Pan X; Li M; Zhao Y
Front Genet; 2022; 13():992995. PubMed ID: 36579333
[No Abstract] [Full Text] [Related]
7. A novel cuproptosis-related prognostic gene signature and validation of differential expression in hepatocellular carcinoma.
Li Y; Zeng X
Front Pharmacol; 2022; 13():1081952. PubMed ID: 36703728
[No Abstract] [Full Text] [Related]
8. A Novel Cuproptosis-Related Prognostic Gene Signature and Validation of Differential Expression in Clear Cell Renal Cell Carcinoma.
Bian Z; Fan R; Xie L
Genes (Basel); 2022 May; 13(5):. PubMed ID: 35627236
[TBL] [Abstract][Full Text] [Related]
9. A novel cuproptosis-related gene signature of prognosis and immune microenvironment in head and neck squamous cell carcinoma cancer.
Jiang X; Ke J; Jia L; An X; Ma H; Li Z; Yuan W
J Cancer Res Clin Oncol; 2023 Jan; 149(1):203-218. PubMed ID: 36376617
[TBL] [Abstract][Full Text] [Related]
10. Identification of cuproptosis-related subtypes, construction of a prognosis model, and tumor microenvironment landscape in gastric cancer.
Wang J; Qin D; Tao Z; Wang B; Xie Y; Wang Y; Li B; Cao J; Qiao X; Zhong S; Hu X
Front Immunol; 2022; 13():1056932. PubMed ID: 36479114
[TBL] [Abstract][Full Text] [Related]
11. Comprehensive analysis of cuproptosis genes and cuproptosis-related genes as prognosis factors in esophageal squamous cell carcinoma.
Wu Z; Huang Z; Zhou X; Gao C; Peng Z; Zheng X; Zhang Y; Du Z; Wu B
Genomics; 2023 Nov; 115(6):110732. PubMed ID: 37866660
[TBL] [Abstract][Full Text] [Related]
12. Identification of two molecular subtypes and a novel prognostic model of lung adenocarcinoma based on a cuproptosis-associated gene signature.
Zhou J; Chen D; Zhang S; Wang C; Zhang L
Front Genet; 2022; 13():1039983. PubMed ID: 36712848
[TBL] [Abstract][Full Text] [Related]
13. Cuproptosis-related genes signature and validation of differential expression and the potential targeting drugs in temporal lobe epilepsy.
Yang X; Zhang X; Shen K; Wang Z; Liu G; Huang K; He Z; Li Y; Hou Z; Lv S; Zhang C; Yang H; Liu S; Ke Y
Front Pharmacol; 2023; 14():1033859. PubMed ID: 37435496
[No Abstract] [Full Text] [Related]
14. Identification of cuproptosis-related genes for predicting the development of prostate cancer.
Wang X; Chen X; Xu C; Zhou W; Wu D
Open Med (Wars); 2023; 18(1):20230717. PubMed ID: 37711156
[TBL] [Abstract][Full Text] [Related]
15. The cuproptosis related genes signature predicts the prognosis and correlates with the immune status of clear cell renal cell carcinoma.
Sun P; Xu H; Zhu K; Li M; Han R; Shen J; Xia X; Chen X; Fei G; Zhou S; Wang R
Front Genet; 2022; 13():1061382. PubMed ID: 36531222
[No Abstract] [Full Text] [Related]
16. Comprehensive analysis of cuproptosis-related prognostic gene signature and tumor immune microenvironment in HCC.
Qin H; Sheng W; Zhang G; Yang Q; Yao S; Yue Y; Zhang P; Zhu Y; Wang Q; Chen Y; Zeng H; Weng J; Yu F; Yang J
Front Genet; 2023; 14():1094793. PubMed ID: 36891150
[No Abstract] [Full Text] [Related]
17. A cuproptosis-related gene signature and associated regulatory axis in stomach adenocarcinoma based on bioinformatics analysis.
Ding D; Wang D; Qin Y
Medicine (Baltimore); 2023 Jul; 102(30):e34230. PubMed ID: 37505170
[TBL] [Abstract][Full Text] [Related]
18. Characterization of a cuproptosis-related signature to evaluate immune features and predict prognosis in colorectal cancer.
Li L; Sun F; Kong F; Feng Y; Song Y; Du Y; Liu F; Kong X
Front Oncol; 2023; 13():1083956. PubMed ID: 37384293
[TBL] [Abstract][Full Text] [Related]
19. System analysis based on the cuproptosis-related genes identifies LIPT1 as a novel therapy target for liver hepatocellular carcinoma.
Yan C; Niu Y; Ma L; Tian L; Ma J
J Transl Med; 2022 Oct; 20(1):452. PubMed ID: 36195876
[TBL] [Abstract][Full Text] [Related]
20. Regulation, genomics, and clinical characteristics of cuproptosis regulators in pan-cancer.
Zhou C; Li C; Zheng Y; Huang X
Front Oncol; 2022; 12():934076. PubMed ID: 36387247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]